185 related articles for article (PubMed ID: 26275671)
21. Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study.
Klovaite J; Benn M; Nordestgaard BG
J Intern Med; 2015 May; 277(5):573-84. PubMed ID: 25161014
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.
Wolpin BM; Kraft P; Gross M; Helzlsouer K; Bueno-de-Mesquita HB; Steplowski E; Stolzenberg-Solomon RZ; Arslan AA; Jacobs EJ; Lacroix A; Petersen G; Zheng W; Albanes D; Allen NE; Amundadottir L; Anderson G; Boutron-Ruault MC; Buring JE; Canzian F; Chanock SJ; Clipp S; Gaziano JM; Giovannucci EL; Hallmans G; Hankinson SE; Hoover RN; Hunter DJ; Hutchinson A; Jacobs K; Kooperberg C; Lynch SM; Mendelsohn JB; Michaud DS; Overvad K; Patel AV; Rajkovic A; Sanchéz MJ; Shu XO; Slimani N; Thomas G; Tobias GS; Trichopoulos D; Vineis P; Virtamo J; Wactawski-Wende J; Yu K; Zeleniuch-Jacquotte A; Hartge P; Fuchs CS
Cancer Res; 2010 Feb; 70(3):1015-23. PubMed ID: 20103627
[TBL] [Abstract][Full Text] [Related]
23. Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients.
Choi S; Lee KW; Bang SM; Kim S; Lee JO; Kim YJ; Kim JH; Park YS; Kim DW; Kang SB; Kim JS; Oh D; Lee JS
Thromb Haemost; 2011 Dec; 106(6):1084-94. PubMed ID: 22072215
[TBL] [Abstract][Full Text] [Related]
24. ABO blood group alleles and the risk of pancreatic cancer in a Japanese population.
Nakao M; Matsuo K; Hosono S; Ogata S; Ito H; Watanabe M; Mizuno N; Iida S; Sato S; Yatabe Y; Yamao K; Ueda R; Tajima K; Tanaka H
Cancer Sci; 2011 May; 102(5):1076-80. PubMed ID: 21306478
[TBL] [Abstract][Full Text] [Related]
25. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.
Secin FP; Jiborn T; Bjartell AS; Fournier G; Salomon L; Abbou CC; Haber GP; Gill IS; Crocitto LE; Nelson RA; Cansino Alcaide JR; Martínez-Piñeiro L; Cohen MS; Tuerk I; Schulman C; Gianduzzo T; Eden C; Baumgartner R; Smith JA; Entezari K; van Velthoven R; Janetschek G; Serio AM; Vickers AJ; Touijer K; Guillonneau B
Eur Urol; 2008 Jan; 53(1):134-45. PubMed ID: 17597288
[TBL] [Abstract][Full Text] [Related]
26. Metformin use is associated with better survival of diabetic patients with pancreatic cancer.
Sadeghi N; Abbruzzese JL; Yeung SC; Hassan M; Li D
Clin Cancer Res; 2012 May; 18(10):2905-12. PubMed ID: 22465831
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.
Antwi SO; Bamlet WR; Pedersen KS; Chaffee KG; Risch HA; Shivappa N; Steck SE; Anderson KE; Bracci PM; Polesel J; Serraino D; La Vecchia C; Bosetti C; Li D; Oberg AL; Arslan AA; Albanes D; Duell EJ; Huybrechts I; Amundadottir LT; Hoover R; Mannisto S; Chanock SJ; Zheng W; Shu XO; Stepien M; Canzian F; Bueno-de-Mesquita B; Quirós JR; Zeleniuch-Jacquotte A; Bruinsma F; Milne RL; Giles GG; Hébert JR; Stolzenberg-Solomon RZ; Petersen GM
Carcinogenesis; 2018 Jul; 39(8):1056-1067. PubMed ID: 29800239
[TBL] [Abstract][Full Text] [Related]
28. Re: ABO blood group and the risk of pancreatic cancer.
Maisonneuve P; Iodice S; Löhr JM; Lowenfels AB
J Natl Cancer Inst; 2009 Aug; 101(16):1156; author reply 1156-7. PubMed ID: 19592664
[No Abstract] [Full Text] [Related]
29. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
[TBL] [Abstract][Full Text] [Related]
30. Thrombotic complications of pancreatic cancer: classical knowledge revisited.
Dumitrascu DL; Suciu O; Grad C; Gheban D
Dig Dis; 2010; 28(2):350-4. PubMed ID: 20814211
[TBL] [Abstract][Full Text] [Related]
31. [Pulmonary embolism of paraneoplastic origin].
Cafagna D; Ponte E
Minerva Med; 1997 Dec; 88(12):523-30. PubMed ID: 9540782
[TBL] [Abstract][Full Text] [Related]
32. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study.
Wang CC; Lin CL; Wang GJ; Chang CT; Sung FC; Kao CH
Thromb Haemost; 2015 Jan; 113(1):185-92. PubMed ID: 25318828
[TBL] [Abstract][Full Text] [Related]
33. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas.
Streiff MB; Segal J; Grossman SA; Kickler TS; Weir EG
Cancer; 2004 Apr; 100(8):1717-23. PubMed ID: 15073862
[TBL] [Abstract][Full Text] [Related]
34. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
[TBL] [Abstract][Full Text] [Related]
35. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
36. Symptomatic venous thromboembolism following fractures distal to the knee: a nationwide Danish cohort study.
Wahlsten LR; Eckardt H; Lyngbæk S; Jensen PF; Fosbøl EL; Torp-Pedersen C; Gislason GH; Olesen JB
J Bone Joint Surg Am; 2015 Mar; 97(6):470-7. PubMed ID: 25788303
[TBL] [Abstract][Full Text] [Related]
37. Independent Predictors of 30-Day Perioperative Deep Vein Thrombosis in 1346 Consecutive Patients After Spine Surgery.
Wang TY; Sakamoto JT; Nayar G; Suresh V; Loriaux DB; Desai R; Martin JR; Adogwa O; Moreno J; Bagley CA; Karikari IO; Gottfried ON
World Neurosurg; 2015 Dec; 84(6):1605-12. PubMed ID: 26171892
[TBL] [Abstract][Full Text] [Related]
38. ABO blood type/Rh factor and the incidence and outcomes for patients with triple-negative breast cancer.
Yu J; Gao F; Klimberg VS; Margenthaler JA
Ann Surg Oncol; 2012 Oct; 19(10):3159-64. PubMed ID: 22878611
[TBL] [Abstract][Full Text] [Related]
39. Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade.
Jawitz OK; G Jawitz N; Yuh DD; Bonde P
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1239-45; discussion 1245-6. PubMed ID: 23978472
[TBL] [Abstract][Full Text] [Related]
40. ABO Blood Group and Diabetes Mellitus Influence the Risk for Pancreatic Cancer in a Population from China.
Li X; Xu H; Gao P
Med Sci Monit; 2018 Dec; 24():9392-9398. PubMed ID: 30582832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
